The molecular biology underlying the metastatic process in ovarian carcinom
a remains poorly understood. For other neoplasms, the induction of angiogen
esis by malignant cells has been shown to play a pivotal role in the proces
s of tumor proliferation and metastasis, The purpose of this study was to c
haracterize the degree of angiogenesis in epithelial ovarian malignancies a
nd to determine whether the degree of neovascularization has prognostic sig
nificance for survival,
Tissue sections obtained from 88 ovarian cancer patients were examined immu
nohistochemically for angiogenesis after staining with anti-human endotheli
al cell antibodies to von Willebrand factor and CD31, Light microscopy was
performed, and individual microvessel counts were quantified at high power
(x400), A chart review was completed, collating data regarding age, stage,
grade, status of disease, and survival. Statistical exploratory methods wer
e used to find potentially useful prognostic cutpoints for marker values of
angiogenesis,
Of the total 88 patients, tissue microvessel counts from 85 were evaluated
via antibodies to von Willebrand factor and 87 for CD31, Overall, median su
rvival was 2.7 years in women with cancers containing high microvessel coun
ts versus 7.9 gears in those with low microvessel counts (P = 0.03). A low
microvessel count was associated with better 5-year survival in both early
stage (I and II) and advanced stage (III and IV) disease.
Our data suggest that the degree of neovascularization may have prognostic
significance in epithelial ovarian carcinoma, especially for women with ear
ly-stage disease. In this group of women, the degree of angiogenesis may al
low the selection of women at high risk for recurrence who may benefit from
aggressive adjuvant therapy.